iNKT cells have some unique beneficial biological properties which make them the ideal candidate for adoptive cell transfer to treat cancer such as the synergistic mechanism between the inherent anti-tumor activity against CD1d harboring cancer cells and the induction of host CD8+ T cell responses. The gene discussed is CD8A; the disease is neoplasm.